JAN 11, 2017 4:46 PM PST

Insight Into how Cancer Cells Overcome Abnormalities & Grow

WRITTEN BY: Carmen Leitch

In the following video from the Francis Crick Institute, you can get a look at why cancer cells are able to proliferate rapidly despite chromosomal abnormalities. It is based on two new papers, one published in Cancer Cell and one in Cancer Discovery.

Normally, healthy cells will self-destruct if it has genetic damage that can’t be fixed, and that damages DNA won’t be passed on. In cancer cells, however, where there is myriad genetic disorder, they are still able to replicate and spread. During their growth they are also able to evade treatment strategies.

One of the studies, in Cancer Discovery, showed that cancerous cells have to avoid accumulating too much damage, as there seems to be a limit to what is tolerable. In that work, researchers reported that cancer cells are able to get by while carrying myriad chromosomal abnormalities because of a slowdown in cellular machinery called APC/C. The cancerous cells can thus get away without making too many mistakes with their daughter cells, increasing genetic diversity in a tumor.

"The development and progression of cancer is fuelled by an unstable genome. It can cause a high degree of diversity between cells, influencing how well treatments work and drug resistance. If a cancer cell can cope with large scale changes to its DNA then it might gain an advantage that helps it to grow, spread and survive treatment. Until now, we knew very little about how these cancer cells kept growing and evolving,” said Professor Charles Swanton, who led the research team at the Francis Crick Institute in London.

"We hope that understanding these mechanisms will allow us to limit drug resistance and improve the efficacy of cancer therapies," he continued.

The other work, in Cancer Cell, showed an increase in mutations in a specific gene in cancerous bowel cells. In normal cells, that gene, BCL9L, helps activate a protein involved in the cell’s self-destruct mechanism. When BCL9L was inactivated, cells with an uneven number of chromosomes were able to continue otherwise normal growth.

In patients that carry tumor cells with an incorrect number of chromosomes, there can be worse outcomes because of cancer evolution and resistance to drug therapies.

"These two studies reveal more about how cancer cells are able to survive with a genetic makeup that would lead to the death of normal cells. This opens the door to potentially exciting new ways to target cancer cells - by exploiting the genetic chaos that lies at the heart of some cancers,” commented Professor Karen Vousden, Chief Scientist at Cancer Research UK.

 

Sources: Francis Crick Institute, Cancer Cell, Cancer Discovery

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 22, 2021
Cancer
A New Treatment Option for Patients with Cancer in the Eye
NOV 22, 2021
A New Treatment Option for Patients with Cancer in the Eye
Uveal melanoma (UM) is a rare malignancy characterized by the formation of cancer cells in the tissues of the eye. UM be ...
DEC 03, 2021
Cell & Molecular Biology
Researchers Create Living Robots That Can Self-Replicate
DEC 03, 2021
Researchers Create Living Robots That Can Self-Replicate
In this image by Douglas Blackiston and Sam Kriegman, a red parent is seen with its green 'offspring'
DEC 08, 2021
Genetics & Genomics
GenElute™-E Single Spin DNA and RNA Purification Technology
DEC 08, 2021
GenElute™-E Single Spin DNA and RNA Purification Technology
Scientists in diverse lab settings often seek optimized technologies and methodologies that improve the quality of their ...
DEC 09, 2021
Cell & Molecular Biology
Using Deep Learning to "Hallucinate" New Proteins
DEC 09, 2021
Using Deep Learning to "Hallucinate" New Proteins
Artificial intelligence is being applied to a lot of fields. In medicine, for example, artificial intelligence has been ...
DEC 23, 2021
Clinical & Molecular DX
Broken Cell "Cleaning Systems" and Schizophrenia
DEC 23, 2021
Broken Cell "Cleaning Systems" and Schizophrenia
A new study in Molecular Psychiatry has brought forward two new biomarkers of schizophrenia and opened up the ...
DEC 31, 2021
Cell & Molecular Biology
Cells Found to Release Super Small Bioactive Particles Called Supermeres
DEC 31, 2021
Cells Found to Release Super Small Bioactive Particles Called Supermeres
We know that cells are constantly secreting molecules that can have many different biological impacts; the term extracel ...
Loading Comments...